![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 17, 2017 7:54:52 PM
We are where we are as we have phase 1 numbers period. Our biggest trial is with 20 humans. What big pharma is going to agree on a licensing agreement on Pluristem's terms without significant stats on a significant population. Sure they will throw cash as some, but not likely what the twins are asking. Just because they're phase 3, doesn't mean jack right now. They're really not a phase 3 company by normal measures. Really think about it honestly and you may see the light like I did.
Having good results from a trial with actual phase 2 enrolment numbers would change that. If I/C numbers are good, then maybe we will see a partnership with teeth. Unfortunately we have to wait until April.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM